Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
amyloidosis
amyotrophic lateral sclerosis
arthrogryposis multiplex
beta adrenergic agonist
Charcot-Marie-Tooth
dermatomyositis
differential diagnosis
emergencies, neurologic
gene mutation
Guillain Barre syndrome
iatrogenic neurologic disorders
klippel feil syndrome
misdiagnosis
mononeuropathy
motor neuron disease
muscle diseases, characteristics of
muscle weakness, proximal
muscle, metabolic disorders of
muscular dystrophy
muscular dystrophy, Duchenne
muscular dystrophy, facioscapulohumeral
muscular dystrophy, limb-girdle
myasthenia gravis
myasthenic crisis
myopathy
myopathy, carcinomatous
myopathy, thyroid disease causing
myositis
myotonia
myotonia dystrophica
myotonic crisis
neuritis, causes of
neuropathy
neuropathy, diabetic
PICU
poliomyelitis
polymyositis
polyneuropathy
porphyria
precipitating factors
respiratory tract infection
rigidity
sarcoidosis
stiff man syndrome
torticollis
treatment of neurologic disorder
Werdnig-Hoffman disease
Showing articles 50 to 100 of 311 << Previous Next >>

Acute Silent Cerebral Ischemic Events in Children with Sickle Cell Anemia
JAMA Neurol 70:58-65, Quinn, C.,et al, 2013

Clinicopathologic Conferences, Celiac Disease, Addisons Disease, and Major Depression Disorder
NEJM 368:2015-2024, Case 16-2013, 2013

Clinicopathologic Conference,Necrotizing Noninflammatory Myopathy Consistent with Exposure to Statins
NEJM 36:944-954, Case 7-2012, 2012

Electrophysiological Study with Prophylactic Pacing and Survival in Adults with Myotonic Dystrophy and Conduction System Disease
JAMA 307:1292-1301, Wahbi,K.,et al, 2012

Cerebral Fat Embolism Syndrome in Sickle Cell Anaemia/�-Thalassemia: Importance of Susceptibility-weighted MRI
Clin Radiol 67:1023-1026, Mossa-Basha, M.,et al, 2012

Black Tongue Due to Adrenocortical Insufficiency
Arch Dis Child 97:1033, de Benedictis, F.M.,et al, 2012

Addisons Disease
Contemp Clin Dent 3:484-486, Sarkar, S.B.,et al, 2012

Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:227-276, Furie,K.L.,et al, 2011

Treatment of Severe Neurological Deficits with IgG Depletion through Immunoadsorption in Patients with Escherichia coli O104:H4-Associated Haemolytic Uraemic Syndrome: A Prospective Trial
Lancet 378:1166-1173,1120, Greinacher, A.,et al, 2011

Cancer Risk Among Patients with Myotonic Muscular Dystrophy
JAMA 306:2480-2486, Gadalla, S.M.,et al, 2011

Cervical Carotid Artery Disease in Sickle Cell Anemia: Clinical and Radiological Features
Blood 118:6192-6199, Telfer, P.T.,et al, 2011

Comparative Analysis of Therapeutic Options Used for Myasthenia Gravis
Ann Neurol 68:797-805, Mandawat,A.,et al, 2010

Neuropsychological Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adults With Sickle Cell Anemia
JAMA 303:1823-1831, Vichinsky,E.P., et al, 2010

Mexiletine Is an Effective Antimyotonia Treatment in Myotonic Dystrophy Type 1
Neurol 74:1441-1448, Logigian,E.L., et al, 2010

Moyamoya Disease and Moyamoya Syndrome
NEJM 360:1226-1237, Scott,R.M. &Smith,E.R., 2009

Incidence and Mortality Rates of Myasthenia Gravis and Myasthenic Crisis in US Hospitals
Neurol 72:1548-1554, Alshekhlee,A.,et al, 2009

The Floppy Infant: Evaluation of Hypotonia
Pediatrics in Review 30:e66-e76, Peredo, D. & Hannibal M., 2009

Pituitary and Stalk Lesions (Infundibulo-Hypophysitis) Associated with Immunoglobulin G4-related Systemic Disease: an Emerging Clinical Entity
Endo J 56:1033-1041, Shimatsu, A.,et al, 2009

The Addisons Disease Dilemma--Autoimmune or ALD?
Lancet 371:1970, Kong,M.-F.,et al, 2008

Electrocardiographic Abnormalities and Sudden Death in Myotonic Dystrophy Type 1
NEJM 358:2688-2697, Groh,W.J.,et al, 2008

Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young
Stroke 39:2644-2691, Roach,E.S.,et al., 2008

Distinct Imaging Patterns and Lesion Distribution in Posterior Reversible Encephalopathy Syndrome
AJNR 28:1320-1327, Bartynski,W.S.,et al, 2007

Reversible Posterior Leukoencephalopathy Syndrome in Catastrophic Antiphospholipid Syndrome
Cerebrovasc Dis 24:141-143, Renard,D.,et al, 2007

Managing Acute Organophosphorus Pesticide Poisoning
BMJ 334:629-634, Roberts,D.M.&Aaron,C.K., 2007

A Diagnostic Approach to Multiple Simultaneous Intracerebral Hemorrhages
Neurocrit Care 4:267-271, Finelli,P.F., 2006

Posterior Reversible Encephalopathy Syndrome in Infection, Sepsis, and Shock
AJNR 27:2179-2190, Bartynski,W.S.,et al, 2006

Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 37:577-617, Sacco,R.L.,et al, 2006

Discontinuing Prophylactic Transfusions Used to Preven Stroke in Sickle Cell Disease
NEJM 353:2769-2778,2743, The Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators, 2005

Adrenoleukodystrophy
JAMA 294:3131-3134, Moser,H.W.,et al, 2005

Apoplexy in Pituitary Macroadenoma: Eight Patients Presenting in 12 Months
Medicine 84:188-196, Imboden,E.,e tal, 2005

Reversible Posterior Leukoencephalopathy Syndrome
Intern Med J 35:83-90, Stott,V.L.,et al, 2005

Upward Transtentorial Herniation, Hydrocephalus, and Cerebellar Edema in Hypertensive Encephalopathy
Neurologist 11:171-175, Adamson, C.D.,et al, 2005

Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping
Nueroradiology 46:978-983, Ahn, K.J.,et al, 2004

Therapy for Nerve Agent Poisoning
Arch Neurol 61:649-652, Newmark,J., 2004

Brainstem Involvement in Hypertensive Encephalopathy
Neurol 62:1417-1419, Cruz-Flores,S.,et al, 2004

Aromatic L-Amino Acid Decarboxylase Deficiency
Neurol 62:1058-1065, Pons,R.,et al, 2004

Severe Cardiac Arrhythmias in Young Patients with Myotonic Dystrophy Type 1
Neurol 63:1939-1941, Bassez,G.,et al, 2004

Sudden Cardiac Death in Myotonic Dystrophy Type 2
Neurol 63:2402-2404, Schoser,B.G.H.,et al, 2004

Encephalitis lethargica syndrome:20 new cases and evidence of basal ganglia autoimmunity
Brain 127, 21-33, Dale, R.C., et al, 2003

Myotonic Dystrophy Type 2
Neurol 60:657-664, Day,J.W.,et al, 2003

Pernicious Anemia with Neuropsychiatric Dysfunction in a Patient with Sickle Cell Anemia Treated with Folate Supplementation
NEJM 348:2204-2207, Dhar,M.,et al, 2003

Risk of Stroke in Children
Neurol 61:189-194, Fullerton,H.J.,et al, 2003

Brain Injury in Children with Sickle Cell Disease: Prevalence and Etiology
Ann Neurol 54:564-572,559, Steen,R.G.,et al, 2003

An Unconsious Girl with Sickle-Cell Disease
Lancet 361:136, van Mierlo,T.D.,et al, 2003

Modafinil Reduces Excessive Somnolence and Enhances Mood in Patients With Myotonic Dystrophy
Neurol 59:1876-1880, MacDonald,J.E.,et al, 2002

Sickle Cell Disease: The Neurological Complications
Ann Neurol 51:543-552, Prengler,M.,et al, 2002

Delayed Neuropathy and Myelopathy After Organophosphate Intoxication
NEJM 347:1119-1121, Chuang,C.,et al, 2002

Improved Cerebrovascular Patency Following Therapy in Patients with Sickle Cell Disease: Initial Results in 4 Patients Who Received HLA-Identical Hematopoietic Stem Cell Allografts
Ann Neurol 49:222-229, Steen,R.G.,et al, 2001

Stroke Prevention and Treatment in Sickle Cell Disease
Arch Neurol 58:565-568, Adams,R.J., 2001

Clinicopath Conf,Systemic Sclerosis with Scleroderma Renal Crisis
NEJM 345:596-605, Case 26-2001, 2001



Showing articles 50 to 100 of 311 << Previous Next >>